These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16949262)

  • 1. A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products.
    Pérez P; Suñé-Negre JM; Miñarro M; Roig M; Fuster R; García-Montoya E; Hernández C; Ruhí R; Ticó JR
    Eur J Pharm Biopharm; 2006 Nov; 64(3):351-9. PubMed ID: 16949262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preformulation studies for direct compression suitability of cefuroxime axetil and paracetamol: a graphical representation using SeDeM diagram.
    Singh I; Kumar P
    Acta Pol Pharm; 2012; 69(1):87-93. PubMed ID: 22574511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (IH) and relative humidity (%RH).
    Suñé-Negre JM; Pérez-Lozano P; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2011 Oct; 79(2):464-72. PubMed ID: 21501683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SeDeM expert system a new innovator tool to develop pharmaceutical forms.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Miñarro M; Ticó JR
    Drug Dev Ind Pharm; 2014 Feb; 40(2):222-36. PubMed ID: 23343308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression.
    Saurí J; Millán D; Suñé-Negre JM; Pérez-Lozano P; Sarrate R; Fàbregas A; Carrillo C; Miñarro M; Ticó JR; García-Montoya E
    Int J Pharm; 2014 Jan; 461(1-2):38-45. PubMed ID: 24284019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of NIR in early stage formulation development. Part I. Semi-quantitative blend uniformity and content uniformity analyses by reflectance NIR without calibration models.
    Li W; Bashai-Woldu A; Ballard J; Johnson M; Agresta M; Rasmussen H; Hu S; Cunningham J; Winstead D
    Int J Pharm; 2007 Aug; 340(1-2):97-103. PubMed ID: 17467204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First study of the evolution of the SeDeM expert system parameters based on percolation theory: Monitoring of their critical behavior.
    Galdón E; Casas M; Gayango M; Caraballo I
    Eur J Pharm Biopharm; 2016 Dec; 109():158-164. PubMed ID: 27769825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H; Hamman J; Wessels A; Scholtz J; Steenekamp J
    Pharm Dev Technol; 2019 Feb; 24(2):145-156. PubMed ID: 29394129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SeDeM Expert System, an Innovative Tool for Developing Directly Compressible Tablets: A Review.
    Singh I; Thakur AK; Bala R; Madan R
    Curr Drug Res Rev; 2021; 13(1):16-24. PubMed ID: 32988362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New classification of directly compressible (DC) excipients in function of the SeDeM Diagarm Expert System.
    Suñé-Negre JM; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Pérez-Lozano P; Miñarro M; Ticó JR
    Int J Pharm; 2014 Aug; 470(1-2):15-27. PubMed ID: 24792976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System.
    Zieschang L; Klein M; Jung N; Krämer J; Windbergs M
    Eur J Pharm Biopharm; 2019 Nov; 144():68-78. PubMed ID: 31493511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of Direct Compression Zidovudine Tablets to Correlate the SeDeM Diagram Expert System and the Rotary Press Simulator Styl'ONE Results.
    Nofrerias I; Nardi A; Suñé-Pou M; Suñé-Negre JM; García-Montoya E; Pérez-Lozano P; Miñarro M; Bataille B; Ticó JR
    AAPS PharmSciTech; 2019 Nov; 21(1):1. PubMed ID: 31712905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the implementation of SeDeM and SSCD in various formulation developments.
    Gaikwad SS; Kothule AM; Morade YY; Patil SS; Laddha UD; Kshirsagar SJ; Salunkhe KS
    Int J Pharm; 2023 Mar; 635():122699. PubMed ID: 36764417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system.
    Gülbağ S; Yılmaz Usta D; Gültekin HE; Oktay AN; Demirtaş Ö; Karaküçük A; Çelebi N
    Pharm Dev Technol; 2018 Jun; 23(5):512-519. PubMed ID: 28657404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.